What is the market capitalization of Nanobiotix S.A.?

Nanobiotix S.A. (NBTX) has a market capitalization of approximately 1,785,132,061 USD.

Where can I buy NBTX in Canada?

NBTX can be purchased through any Canadian online broker including Wealthsimple, Questrade, Qtrade, or RBC Direct Investing.

NBTX

Nanobiotix S.A.

Nanobiotix S.A. (NBTX) is a France company in the healthcare sector, listed on NASDAQ. Market capitalization of 1.8 billion USD (small-cap).

Details

Price35.20 USD

Market cap1.79 G USD

Payout ratio0.00%

SectorHealthcare

Websitenanobiotix.com

Updated 1h ago

Nanobiotix S.A. operates as a clinical-stage biotechnology that focuses on developing product candidates for the treatment of cancer and other unmet medical needs. Its lead product candidate is NBTXR3, a sterile aqueous suspension of crystalline hafnium oxide nanoparticles used for the treatment of soft tissue sarcoma, head and neck, liver, prostate, pancreatic, esophageal, rectal, and non-small cell lung cancer. The company has a partnership with Lian Oncology Limited to develop and commercialize NBTXR3 in China, South Korea, Singapore, and Thailand. Nanobiotix S.A. was incorporated in 2003 and is based in Paris, France.